AJ Bell funds
Catch these star turn investment trusts on the way up
In the same way investors can make a mint by backing a mythical ‘10-bagger’ early doors, fund fanatics can make big gains by catching an...
Thu, 23/09/2021 - 00:00
Help, I don’t understand the flexi-access options for pensions
I want to take annual lump sums from my pension pot in retirement, each made up of a 25% tax-free component and the balance in...
The new look FTSE 100: How the index might evolve in 2022 and beyond
The FTSE 100 is poised for some significant changes in the coming 12 months such as the removal of BHP (BHP) from the...
A brighter outlook for property makes this 5% yielding trust a bargain
The outlook for UK commercial property has improved in the wake of the roll-out of vaccines and as workers return to the office. However, this...
AstraZeneca breakthrough makes up for Covid vaccine setback
Many of the Covid-19 headlines that pharma giant AstraZeneca (AZN) has attracted over the past 18 months haven’t really had much impact on...
Want Asia exposure but worried about China? Try Vietnam
As Chinese markets continues their collapse, driven initially by the heavy-handed treatment of technology stocks by the authorities and more recently by a collapse in...
Close to 50% gain from Equals since April, more to come?
Equals (EQLS:AIM) 63.99p Gain to date: 48.8% Original entry point: Buy at 43p, 29 April 2021
Payments group Equals (...
Shell picks up pace with transition away from oil and gas
The $9.5 billion sale of assets in the core oil producing Permian basin in the US suggests Royal Dutch Shell (RDSB) is doing...
Why this Japanese trust has gained 15% in a month
JPMorgan Japanese (JFJ) 723p Gain to date: 32% Original entry point: Buy at 547.92p, 2 July 2020
After a...
Alliance Pharma's growth potential remains underappreciated
Alliance Pharma (APH:AIM) 104p Gain to date: 45.3% Original entry point: Buy at 71.6p, 3 October 2019
Pharmaceutical specialist Alliance...
